The molecular rationale of Src inhibition in colorectal carcinomas
about
Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic MacrocyclesEpidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysThe Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer.Epithelial regeneration and cancer: news from the Src front.The importance of Src signaling in sarcoma.Characterization of an Engineered Src Kinase to Study Src Signaling and BiologyDiscovery of novel dual VEGFR2 and Src inhibitors using a multistep virtual screening approach.Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis.Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.Deciphering signaling networks in osteosarcoma pathobiology.Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.Protein trafficking in colorectal carcinogenesis-targeting and bypassing resistance to currently applied treatments.Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer.'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis.
P2860
Q27727987-0B222009-801C-4A22-B994-AAA65970C847Q33737298-A4F65663-9CF2-4B75-AC8F-916085A638F9Q33776733-B3853AD7-3E10-4595-821E-1B44CA27A166Q34324502-347AEA10-FF75-4416-AA8C-9C091AA428A3Q35802929-F889AA16-7851-49A6-87B5-1082FAE40B63Q36210533-593D1E4E-3928-41EF-B81B-216DBA3E8AC6Q36229209-9987CF83-8768-4689-869D-44B33103598EQ36339714-3F2E1274-62B6-4ECE-8EEB-689F68B26557Q36777632-EA435987-5BC7-4DEF-A4EC-30C8C0CA6E18Q37106930-6C9FFB05-8496-4A7D-85D1-72E37FAB2DA6Q37362851-4558CD59-E9A1-4455-A380-200F833BE7A2Q38415868-F0F8C588-30BA-4349-800D-1349BC241E22Q42085487-A8DD5247-8A68-4F54-85CF-F9483DFEB25BQ47648692-0625B46D-3FD7-492B-9E7F-0AC65EECF325Q49805700-C76DA2AF-46CE-426D-89EF-DB25FDC85783
P2860
The molecular rationale of Src inhibition in colorectal carcinomas
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The molecular rationale of Src inhibition in colorectal carcinomas
@ast
The molecular rationale of Src inhibition in colorectal carcinomas
@en
The molecular rationale of Src inhibition in colorectal carcinomas
@nl
type
label
The molecular rationale of Src inhibition in colorectal carcinomas
@ast
The molecular rationale of Src inhibition in colorectal carcinomas
@en
The molecular rationale of Src inhibition in colorectal carcinomas
@nl
prefLabel
The molecular rationale of Src inhibition in colorectal carcinomas
@ast
The molecular rationale of Src inhibition in colorectal carcinomas
@en
The molecular rationale of Src inhibition in colorectal carcinomas
@nl
P2093
P2860
P3181
P356
P1476
The molecular rationale of Src inhibition in colorectal carcinomas
@en
P2093
Antonios N. Gargalionis
Athanasios G. Papavassiliou
Michalis V. Karamouzis
P2860
P304
P3181
P356
10.1002/IJC.28299
P407
P577
2014-05-01T00:00:00Z